1.800.979.8292
Miraca Life Sciences
Serving more than 3,000 patients each day,
We employ a talented team of leading pathologists, histologists, molecular pathology experts, lab technicians and other medical professionals. Our commitment to scientific excellence drives our hiring decisions and informs everything we do.
FOR CARIS TARGET NOW™
AND CARISOME™
Caris Target Now Molecular Profiling and Carisome Circulating Microvesicle Technology are owned by Caris Life Sciences, Ltd.
Information about these innovative technologies can be found at CarisLifeSciences.com.
Recent News
May 1, 2012
Dr. Frank Basile Joins Miraca Life Sciences as President and Chief Executive Officer
Experienced Healthcare Veteran to Implement New Growth Strategy Dallas, TX, May 1, 2012 – Miraca Life Sciences, Inc. (“MLS”), a specialist in the development and commercialization of the highest quality anatomic pathology services, today announced that Dr. Frank Basile will …
Continue reading
February 3, 2012
Miraca Holdings Announces Caris Diagnostics Name Change to Miraca Life Sciences
Company to Provide Same High-Quality Anatomic Pathology Services Under New Name Tokyo, Japan & Irving, Texas, February 3, 2012 - Caris Diagnostics, specializing in academic-caliber anatomic pathology services, today announced a company name change to Miraca Life Sciences, Inc., following …
Continue reading
© 2012
Trademarks are the property of their respective owners.